We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Rapid Blood Test Detects Breast Cancer Markers within 20 Minutes

By LabMedica International staff writers
Posted on 01 Feb 2024
Print article
Image: Researcher Aleksei Kuzin holding the photonic chip that is the sensing component in the new diagnostic platform (Photo courtesy of Skoltech)
Image: Researcher Aleksei Kuzin holding the photonic chip that is the sensing component in the new diagnostic platform (Photo courtesy of Skoltech)

Small extracellular vesicles (sEVs) are biomarkers for breast cancer and take the form of tiny bubbles ranging from 20 to 150 nanometers in size. These vesicles play a crucial role in substance transport and cell communication within the body. Found in blood and other body fluids, sEVs carry various molecules that indicate the presence and stage of breast cancer, with their concentration being a key factor. The traditional method for measuring sEV levels relies on expensive animal-produced antibodies, making it both costly and time-intensive due to the preparation of bodily fluids. Additionally, the instability of antibodies adds to the complications. Now, scientists have developed a new method to diagnose breast cancer markers quickly, within just 15 to 20 minutes, using a minimal amount of blood sample.

The supersensitive system developed by a team of scientists, including researchers from Skoltech (Moscow, Russia), combines photonic sensors and microfluidics to spot breast cancer early on, thereby allowing timely intervention and evaluation of treatment efficacy. The blood test is conducted on a microchip that identifies the sEVs. To gauge the concentration of sEVs, the system utilizes photonic microsensors, which are microchips carrying signals through light particles or photons. The fluid under analysis flows through a very narrow channel, whose walls are coated with specialized 'target' molecules [DARPins] at the intersection with the waveguide carrying light. As the vesicles pass, they adhere to these molecules, and their quantity affects how light moves along the waveguide, a change that is measurable.

According to the researchers, the approach offers several benefits. The molecules deposited on the microchannel walls are smaller and less expensive than antibodies, and the photonic integrated circuits have a relatively simple design to facilitate future mass production. This new breast cancer screening technique could make the procedure more accessible and cost-effective. The device's microtubes are washable, and its sensor’s active layer can be re-applied for reuse. However, experts caution that sEVs are not solely linked to cancer, as all cells produce them in varying quantities based on the body's condition, such as health status and diet. Therefore, careful application of this method is crucial to avoid false positives or negatives.

Nevertheless, the test's simplicity makes it suitable for routine medical examinations. Early detection and appropriate responses could lead to more favorable outcomes. The method’s potential extends to diagnosing other diseases, indicating its scalability. In the future, the device might even facilitate simultaneous screening for multiple diseases. Additionally, the possibility of analyzing other bodily fluids, like urine, may be incorporated as the technology advances. However, while the microchip itself could be inexpensive, the required analysis device might be costly and need specialized operators. The conservative nature of healthcare, often favoring infrastructurally convenient solutions that integrate with existing hardware and do not require personnel retraining, is an important factor in the development of new medical techniques and equipment. The researchers will now further develop the method taking into account its affordability and compatibility with the medical equipment routinely used in clinics.

“Breast cancer diagnostics is an actively developing area of Russian health care. The main advantages of the newly proposed method are the rapid test results, the small amount of biological fluid required, and the capacity for repeated use,” said Irina Shipunova, a senior research scientist at the National Medical Research Center of Hematology.

“Using biophotonics to detect oncomarkers, and tumor-specific microvesicles in particular, is a promising approach. Such solutions could make tests faster,” added Albert Rizvanov from Kazan Federal University.

Related Links:
Skoltech

New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Automated Blood Typing System
IH-500 NEXT
New
Nuclear Matrix Protein 22 Test
NMP22 Test
New
Silver Member
Benchtop Image Acquisition Device
Microwell Imager

Print article

Channels

Clinical Chemistry

view channel
Image: Rapid and non-invasive analysis of paracetamol overdose using paper arrow-mass spectrometry (Photo courtesy of Dr Simon Maher/University of Liverpool)

New Saliva Test Rapidly Identifies Paracetamol Overdose

Paracetamol is the most widely used medication worldwide, and its easy availability contributes to its frequent misuse and overdose. Overdosing on paracetamol can lead to liver toxicity, requiring hospitalization.... Read more

Hematology

view channel
Image: RHD screening just got easier with single exon NIPT testing (Photo courtesy of Devyser)

Non-Invasive Test Solution Determines Fetal RhD Status from Maternal Plasma

RhD (rhesus D) is a blood group type that can trigger immune responses. Individuals who lack RhD on their red blood cells are classified as RhD-negative. These individuals may produce antibodies against... Read more

Immunology

view channel
Image: Concept for the device. Memory B cells able to bind influenza virus remain stuck to channels despite shear forces (Photo courtesy of Steven George/UC Davis)

Microfluidic Chip-Based Device to Measure Viral Immunity

Each winter, a new variant of influenza emerges, posing a challenge for immunity. People who have previously been infected or vaccinated against the flu may have some level of protection, but how well... Read more

Microbiology

view channel
Image: A new test finds bacteria in liquids and indicate their presence by changing color (Photo courtesy of Georgia Kirkos/McMaster University)

New Hands-Free Rapid Test Detects Bacteria in Fluids

Bacteriophages, the most abundant form of life on Earth, are specialized to target and destroy specific types of bacteria. Their natural ability to fight bacteria has long been harnessed to treat infections.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.